BioCentury
ARTICLE | Clinical News

Montelukast sodium regulatory update

August 24, 2015 7:00 AM UTC

Kyorin Pharmaceutical Co. Ltd. (Tokyo:4569), Tokyo, Japan Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Product: Montelukast sodium ( Kipres OD Tablets) Business: Inflammation Kyorin said Japan appro...